Are you interested in taking part in a trial of patients with Psoriasis?
Richmond Pharmacology conducts medical research to help develop new medicines. Our 2 research units, based in London at St George’s University Hospital and Croydon University Hospital, provide you with the safest and most comfortable facilities. Richmond Pharmacology works closely with Hospital Consultants, Research Physicians, and Clinicians ensuring the research we conduct is meaningful, ethical, and safe.
What is this all about?Richmond Pharmacology is conducting a clinical trial for a new experimental drug called FX125L. FX125L is an anti-inflammatory agent being developed for the treatment of chronic inflammatory diseases such as asthma, COPD, RA and psoriasis. It is anticipated that FX125L may be more effective and have fewer side effects compared to the current marketed drugs.
This is the first time FX125L will be given to patients with chronic inflammation. The purpose of this study, therefore, is to examine the impact of treatment with such an agent in patients with a range of different diseases that share a chronic inflammatory component. The purpose of this study is also to collect information on markers which will help us to plan future research studies, to further test the effect of this compound.
The trial is being conducted at Richmond Pharmacology Ltd only.
To qualify for participation in this study you need to:• Be aged between 18 and 77 years (inclusive) at screening
• Have a documented diagnosis of moderate Psoriasis
(with a confirmed medical history available from your GP).
• Stable disease for at least 1 month prior to Screening and have not used any steroids to treat your psoriasis during this time
•
Have at least 5% body surface area covering of psoriasis. • Have a body mass index (BMI) between ≥18.0 and ≤35.0 kg/m2 (inclusive). Your BMI is calculated using the formula: weight (in kilograms) divided by height (in metres) squared).
If the above sounds like this is you then read on:
Study ParticipationParticipation for this study requires you to attend 5 out-patient visits and one residential stay of 1 night and 1 day at our clinical unit at Croydon University Hospital. This includes the screening visit (Visit 1) within 14 to 28 days before the start of the study, one residential stay of 1 night/1 day at our unit (Visit 2), 3 outpatient visits on Days 10, 42 and Day 56 (Visits 3, 4 and 5) and the final follow up visit (Visit 6) after the last dose of the study drug. Your participation in this study will last approximately 17 weeks.
For an example of a study timetable please go to: You are not allowed to view links.
Register or
Login Please Note: There are groups starting on a weekly basis so call us and we will find one that fits with your schedule
Want to find out more?If you are interested in finding out more call us free on 0208 664 5200 and choose option 1 and speak to a member of our Volunteer Recruitment Team.
A detailed information sheet is available on request.
On behalf of the
Richmond Pharmacology Volunteer Recruitment Team
Ref: FXT_Oct 2011
